Compare OPRX & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPRX | EDAP |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.1M | 128.9M |
| IPO Year | 2008 | 1998 |
| Metric | OPRX | EDAP |
|---|---|---|
| Price | $5.07 | $4.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $16.67 | $10.00 |
| AVG Volume (30 Days) | ★ 506.3K | 38.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.55 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $109,429,000.00 | $70,527,000.00 |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $8.34 | $6.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.78 | 1.63 |
| 52 Week Low | $4.57 | $1.21 |
| 52 Week High | $22.25 | $5.05 |
| Indicator | OPRX | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 57.85 |
| Support Level | $4.57 | $3.18 |
| Resistance Level | $7.23 | $4.38 |
| Average True Range (ATR) | 0.36 | 0.26 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 27.00 | 49.20 |
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.